KACTUS

At KACTUS, we specialize in high-activity recombinant proteins and enzymes to accelerate drug and therapeutic development. Our 3,000+ product catalog covers a variety of protein, species, tags, and labels. These rigorously tested products can be applied to a variety of research and drug development areas including antibody drug discovery, cell therapy, gene therapy, and mRNA therapeutics. Each product undergoes strict quality control for purity, performance, consistency, and stability of supply. We’ve developed an expertise in difficult-to-express proteins, including being the first to recombinantly produce full-length Claudin 18.2 protein. Since then, we’ve developed a large catalog of multipass transmembrane proteins, MHC complexes, and other challenging proteins and enzymes. Researchers also value our custom protein expression services, owing to our demonstrated expertise in complex protein expression and responsive support.
Purchase on Scientist.com

The Latest Insights & Innovations from

KACTUS

Webinar

Visualizing Lipid Control of Drug Binding in Membrane Proteins at High Resolution

July 1, 2026
Learn more
Webinar

How to Avoid Expensive Redesign Cycles in Antibody Discovery

May 5, 2026
Learn more
Webinar

Next-Generation TCR-Like Antibodies With Improved Specificity Profiles

March 18, 2026
Learn more
Webinar

Vaccine-Boosting CAR T Cells Against Solid Tumors

September 24, 2025
Learn more
Webinar

Discovery and Engineering of High-Affinity Soluble T Cell Receptors via a High-Throughput Yeast-Based Platform

April 16, 2025
Learn more
No items found.
No items found.